Theseus Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Theseus Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2021 to Q3 2023.
  • Theseus Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $3.92M, a 12.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $3.92M -$545K -12.2% Sep 30, 2023 10-Q 2023-11-17
Q2 2023 $4.06M -$536K -11.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $4.2M -$523K -11.1% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $4.33M Dec 31, 2022 10-Q 2023-11-17
Q3 2022 $4.47M -$235K -5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $4.6M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $4.72M Mar 31, 2022 10-Q 2022-05-12
Q3 2021 $4.7M Sep 16, 2021 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.